Markets
MarketMind AI
Baskets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
All Features
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
Financials
Charts & Report
Charts and Graphs
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Price History/Seasonality
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
(1)
About
Marksans Pharma Ltd.
NSE: MARKSANS
|
BSE: 524404
|
ISIN: INE750C01026
|
Industry: Pharmaceuticals
|
Mid-range Performer
203.2800
5.52
(
2.79
%)
NSE
May 11, 2026
15:31 PM
31.15% Gain from 52W Low
Volume:
3.2M
High vol.+gain this week
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Marksans Pharma Ltd.
04 Oct 2023
203.28
2.79%
MARKSANS PHARMA LTD.
Buy:
Marksans Pharma Ltd.
by
Ventura
Target: 149
Target
Ventura
Consolidating on the back of the Teva acquisition
Marksans Pharma Ltd. high volume past week with price gain of 10.10.
More from Marksans Pharma Ltd.
Recommended
IPO listing pace holds strong: Three more debuts this week after last week's trio
|
11 May 2026, 06:13PM
Market closes lower as US-Iran negotiations come to a standstill
Trendlyne Marketwatch |
11 May 2026, 03:52PM
Marksans Pharma facility receives four observations from US FDA
|
10 Apr 2017, 02:16PM